Ospedale di Oderzo Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2000
NCT00161330
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2000

Timeline

NOW
  • Now

Alternative names

Pediatric Unit, Ospedale di Oderzo, Italy

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 3)

Infections (Phase 3)

Urinary Tract Infections (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 3